Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03109379. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-center, Open-label Study of Trospium Delivered Intravesically by TAR-302-5018 to Subjects With Idiopathic Overactive Bladder (iOAB) and Urinary Incontinence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if TAR-302-5018, an investigational drug-delivery system, is safe and tolerable in patients with idiopathic overactive bladder and urinary incontinence.
Study identification
- NCT ID
- NCT03109379
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 43 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 4, 2017 (Actual)
- Primary completion
- Sep 27, 2019 (Actual)
- Completion
- Sep 27, 2019 (Actual)
- Last update posted
- Jan 13, 2020
2017 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urological Associates of Southern Arizona | Tucson | Arizona | 85715 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| Clinical Research Center of Florida | Pompano Beach | Florida | 33060 | — |
| DelRicht Clinical Research, LLC | New Orleans | Louisiana | 70115 | — |
| Bay State Clinical Trials, Inc | Watertown | Massachusetts | 02472 | — |
| William Beaumont Hospital - Royal Oak | Royal Oak | Michigan | 48073 | — |
| Michigan Institute of Urology | Troy | Michigan | 48084 | — |
| New Jersey Urology | Voorhees Township | New Jersey | 08043 | — |
| Accumed Research | Garden City | New York | 11530-1664 | — |
| Manhattan Medical Resear | New York | New York | 10016 | — |
| UWCR - Lyndhurst Gynecologic Associates | Winston-Salem | North Carolina | 27103 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03109379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2020 · Synced Nov 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.